Tarun Jain
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tarun Jain has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Gina Hurst
Henry Ford Hospital
1 shared publication Gordon Jacobsen
Department of Biostatistics, Henry Ford Hospital, Detroit, Michigan
1 shared publicationJainil Shah
Henry Ford Hospital Health System Detroit Michigan
1 shared publication- Jainil Shah
Department of Internal Medicine, Henry Ford Hospital, 2799 W Grand Blvd, Detroit, MI 48202 USA
1 shared publication James McCord
Department of Biostatistics, Henry Ford Hospital, Detroit, Michigan
1 shared publicationJavier Sanchez
Henry Ford Hospital Health System Detroit Michigan
1 shared publication
Latest Publications
- 1 June 2016
- Published by Wolters Kluwer Health in Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine
- Vol. 15 (2) , 40-45
Short- and Long-Term Prognostic Utility of the HEART Score in Patients Evaluated in the Emergency Department for Possible Acute Coronary Syndrome
Introduction: The HEART score is a risk-stratification tool that was developed and validated for patients evaluated for possible acute coronary syndrome (ACS) in the emergency department (ED). We sought to determine the short-term and long-term prognostic utility of the HEART score. Methods: A retrospective single-center analysis of 947 patients evaluated for possible ACS in the ED in 1999 was conducted. Patients were followed for major adverse cardiac events (MACEs) at 30 days: death, acute myocardial infarction, or revascularization procedure. All-cause mortality was assessed at 5 years. The HEART score was compared with the Thrombolysis in Myocardial Infarction (TIMI) score. Results: At 30 days, 14% (135/947) of patients had an MACE: 48 deaths (5%), 84 acute myocardial infarctions (9%), and 48 (5%) revascularization procedures. The MACE rate in patients with HEART score ≤3 was 0.6% (1/175) involving a revascularization procedure, 9.5% (53/557) in patients with HEART score between 4 and 6, and 38% (81/215) with HEART score ≥7. The C-statistic for the HEART score was 0.82 and 0.68 for the TIMI score for predicting 30-day MACE (P < 0.05). Patients with HEART score ≤3 had lower 5-year mortality rate compared with those with TIMI score of 0 (10.6% vs. 20.5%, P = 0.02). Conclusions: The HEART score is a valuable risk-stratification tool in predicting not only short-term MACE but also long-term mortality in patients evaluated for possible ACS in the ED. The HEART score had a superior prognostic value compared with the TIMI score.
- 1 June 2016
- Published by Wolters Kluwer Health in Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine
- Vol. 15 (2) , 40-45
Short- and Long-Term Prognostic Utility of the HEART Score in Patients Evaluated in the Emergency Department for Possible Acute Coronary Syndrome
Introduction: The HEART score is a risk-stratification tool that was developed and validated for patients evaluated for possible acute coronary syndrome (ACS) in the emergency department (ED). We sought to determine the short-term and long-term prognostic utility of the HEART score. Methods: A retrospective single-center analysis of 947 patients evaluated for possible ACS in the ED in 1999 was conducted. Patients were followed for major adverse cardiac events (MACEs) at 30 days: death, acute myocardial infarction, or revascularization procedure. All-cause mortality was assessed at 5 years. The HEART score was compared with the Thrombolysis in Myocardial Infarction (TIMI) score. Results: At 30 days, 14% (135/947) of patients had an MACE: 48 deaths (5%), 84 acute myocardial infarctions (9%), and 48 (5%) revascularization procedures. The MACE rate in patients with HEART score ≤3 was 0.6% (1/175) involving a revascularization procedure, 9.5% (53/557) in patients with HEART score between 4 and 6, and 38% (81/215) with HEART score ≥7. The C-statistic for the HEART score was 0.82 and 0.68 for the TIMI score for predicting 30-day MACE (P < 0.05). Patients with HEART score ≤3 had lower 5-year mortality rate compared with those with TIMI score of 0 (10.6% vs. 20.5%, P = 0.02). Conclusions: The HEART score is a valuable risk-stratification tool in predicting not only short-term MACE but also long-term mortality in patients evaluated for possible ACS in the ED. The HEART score had a superior prognostic value compared with the TIMI score.
- Open Access
- 10 November 2015
- Published by Springer Nature in Journal of Intensive Care
- Vol. 3 (1) , 1-5
Vancomycin-induced acute generalized exanthematous pustulosis (AGEP) masquerading septic shock—an unusual presentation of a rare disease
Acute generalized exanthematous pustulosis (AGEP) is a rare cutaneous adverse reaction characterized by acute sterile pustular eruptions, mostly induced by medications. Antibiotics are the most commonly implicated drugs; however, there have only been two previous reports of vancomycin-induced AGEP in the literature. In this case, we present the clinical course of a 56-year-old man who was admitted to the intensive care unit with an unusually severe form of AGEP mimicking septic shock, which developed after the recent use of vancomycin. Despite cessation of the offending agent, our patient continued to clinically decline with development of worsening skin eruptions and hemodynamic instability necessitating vasopressor support. The patient promptly responded to systemic steroid therapy with complete resolution of AGEP. In addition to highlighting the implication of vancomycin in AGEP, we herein discuss the clinical presentation, diagnosis, and management of AGEP, particularly in severe cases admitted to the intensive care unit.
- 10 November 2015
- Published by Springer Nature in Journal of Intensive Care
- Vol. 3 (1) , 1-5
Open AccessVancomycin-induced acute generalized exanthematous pustulosis (AGEP) masquerading septic shock—an unusual presentation of a rare disease
Acute generalized exanthematous pustulosis (AGEP) is a rare cutaneous adverse reaction characterized by acute sterile pustular eruptions, mostly induced by medications. Antibiotics are the most commonly implicated drugs; however, there have only been two previous reports of vancomycin-induced AGEP in the literature. In this case, we present the clinical course of a 56-year-old man who was admitted to the intensive care unit with an unusually severe form of AGEP mimicking septic shock, which developed after the recent use of vancomycin. Despite cessation of the offending agent, our patient continued to clinically decline with development of worsening skin eruptions and hemodynamic instability necessitating vasopressor support. The patient promptly responded to systemic steroid therapy with complete resolution of AGEP. In addition to highlighting the implication of vancomycin in AGEP, we herein discuss the clinical presentation, diagnosis, and management of AGEP, particularly in severe cases admitted to the intensive care unit.
- Open Access
- 25 June 2015
- Published by Journal of Case Reports in Journal of Case Reports
- Vol. 5 (1) , 269-270
Ebstein’s Anomaly Assessed by Cardiac MRI
Patients with congenital heart disease present a challenge for imagers, since it requires a profound knowledge of the morphologic and functional characteristics of a broad range of congenital heart defects. Ebstein's anomaly is an uncommon congenital abnormality of tricuspid valve characterized by dysplasia and downward displacement of the septal and posterior leaflets. We present a case of a young male who presented for further cardiac work-up to evaluate for suspected Ebstein's anomaly after prior history of radiofrequency catheter ablation for Wolff-Parkinson-White syndrome. The case highlights the diagnostic utility of cardiac magnetic resonance imaging in identifying the anomaly.
- 25 June 2015
- Published by Journal of Case Reports in Journal of Case Reports
- Vol. 5 (1) , 269-270
Open AccessEbstein’s Anomaly Assessed by Cardiac MRI
Patients with congenital heart disease present a challenge for imagers, since it requires a profound knowledge of the morphologic and functional characteristics of a broad range of congenital heart defects. Ebstein's anomaly is an uncommon congenital abnormality of tricuspid valve characterized by dysplasia and downward displacement of the septal and posterior leaflets. We present a case of a young male who presented for further cardiac work-up to evaluate for suspected Ebstein's anomaly after prior history of radiofrequency catheter ablation for Wolff-Parkinson-White syndrome. The case highlights the diagnostic utility of cardiac magnetic resonance imaging in identifying the anomaly.